Trials

ANGPTL3 inhibitors

Read more about ANGPTL3 inhibitors »

Evinacumab (Evkeeza)View the trials

ZodasiranView the trials

VERVE-201View the trials

SolbinsiranView the trials

Vupanorsen (Pfizer-led clinical development programme discontinued in January 2022)View the trials

Icosapent Ethyl

Read more about Icosapent Ethyl »

Icosapent ethyl (Vascepa)View the trials

SPPARM

Read more about SPPARM »

Pemafibrate (Parmodia)View the trials

ApoCIII inhibitors

Read more about ApoCIII inhibitors »

Volanesorsen (Waylivra)View the trials

Olezarsen (formerly AKCEA-APOCIII-LRx)View the trials

Plozasiran (formerly ARO-APOC3)View the trials

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo